Effect Size Analyses of Souvenaid in Patients with Alzheimer’s Disease

Effect Size Analyses of Souvenaid in Patients with Alzheimer’s Disease

Background: Souvenaid® (uridine monophosphate, docosahexaenoic acid, eicosapentaenoic acid, choline, phospholipids, folic acid, vitamins B12, B6, C, and E, and selenium), was developed to support the formation and function of neuronal membranes.

Bibliographic Details
Main Authors: Cummings, Jeffrey, Scheltens, Philip, McKeith, Ian, Blesa, Rafael, Harrison, John E., Bertolucci, Paulo H.F., Rockwood, Kenneth, Wilkinson, David, Wijker, Wouter, Bennett, David A., Shah, Raj C.
Format: Online
Language:English
Published: IOS Press 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147481/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5147481/

Similar Items